Plasma C24:0- and C26:0-lysophosphatidylcholines are reliable biomarkers for the diagnosis of peroxisomal β-oxidation disorders
Journal of Lipid Research · 2024-03 · 65 (3) · 100516
DOI: 10.1016/j.jlr.2024.100516 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Lipid Research, 2024-03. Verfasst von Blai Morales-Romero und 9 weiteren Autor:innen. Beteiligte Einrichtung: Section of Inborn Errors of Metabolism-IBC, Biochemistry and Molecular Genetics Department, Hospital Clínic de Barcelona, Barcelona, Spain; Biomedica…. Hauptthemen laut MEDLINE: Lysophosphatidylcholines, Adrenoleukodystrophy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AGAUR, CIBER.
Abstract (Originalsprache)
The gold-standard diagnostic test for peroxisomal disorders (PDs) is plasma concentration analysis of very long-chain fatty acids (VLCFAs). However, this method's time-consuming nature and limitations in cases which present normal VLCFA levels necessitates alternative approaches. The analysis of C26:0-lysophosphatydylcholine (C26:0-LPC) in dried blood spot samples by tandem-mass spectrometry (MS/MS) has successfully been implemented in certain newborn screening programs to diagnose X-linked adrenoleukodystrophy (ALD). However, the diagnostic potential of very long-chain LPCs concentrations in plasma remains poorly understood. This study sought to evaluate the diagnostic performance of C26:0-LPC and other very long-chain LPCs, comparing them to VLCFA analysis in plasma. The study, which included 330 individuals affected by a peroxisomal β-oxidation deficiency and 407 control individuals, revealed that C26:0- and C24:0-LPC concentrations demonstrated the highest diagnostic accuracy (98.8% and 98.4%, respectively), outperforming VLCFA when C26:0/C22:0 and C24:0/C22:0 ratios were combined (98.1%). Combining C24:0- and C26:0-LPC gave the highest sensitivity (99.7%), with ALD females exhibiting notably higher sensitivity compared with the VLCFA ratio combination (98.7% vs. 93.5%, respectively). In contrast, C22:0-LPC exhibited suboptimal performance, primarily due to its low sensitivity (75%), but we identified a potential use to help distinguish between ALD and Zellweger spectrum disorders. In summary, MS/MS analysis of plasma C24:0- and C26:0-LPC concentrations represents a rapid and straightforward approach to diagnose PDs, demonstrating superior diagnostic accuracy, particularly in ALD females, compared with conventional VLCFA biomarkers. We strongly recommend integrating very-long chain LPC plasma analysis in the diagnostic evaluation of individuals suspected of having a PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Inborn Errors of Metabolism-IBC, Biochemistry and Molecular Genetics Department, Hospital Clínic de Barcelona, Barcelona, Spain; Biomedical Research Institute August Pi i Sunyer (IDIBAPS), Barcelona, Spain; C…
- Section of Inborn Errors of Metabolism-IBC, Biochemistry and Molecular Genetics Department, Hospital Clínic de Barcelona, Barcelona, Spain.
- CORE Laboratory, Biochemistry and Molecular Genetics Department, Hospital Clínic de Barcelona, Barcelona, Spain.
Förderung
- AGAUR
- CIBER
Zitieren
APA
Morales-Romero, B., González de Aledo-Castillo, J. M., Fernández Sierra, C., Martínez Carreira, C., Zaragoza Bonet, C., Fernández Bonifacio, R., Caro Miró, M. A., Argudo-Ramírez, A., López Galera, R. M., & García-Villoria, J. (2024). Plasma C24:0- and C26:0-lysophosphatidylcholines are reliable biomarkers for the diagnosis of peroxisomal β-oxidation disorders. Journal of Lipid Research, 65(3), 100516. https://doi.org/10.1016/j.jlr.2024.100516
Vancouver
Morales-Romero B, González de Aledo-Castillo JM, Fernández Sierra C, Martínez Carreira C, Zaragoza Bonet C, Fernández Bonifacio R, et al. Plasma C24:0- and C26:0-lysophosphatidylcholines are reliable biomarkers for the diagnosis of peroxisomal β-oxidation disorders. Journal of Lipid Research. 2024;65(3):100516. doi:10.1016/j.jlr.2024.100516
BibTeX
@article{MoralesRomero2024,
author = {Morales-Romero, Blai and González de Aledo-Castillo, José Manuel and Fernández Sierra, Cristina and Martínez Carreira, Carmen and Zaragoza Bonet, Carles and Fernández Bonifacio, Rosa and Caro Miró, Maria Antònia and Argudo-Ramírez, Ana and López Galera, Rosa María and García-Villoria, Judit},
title = {Plasma C24:0- and C26:0-lysophosphatidylcholines are reliable biomarkers for the diagnosis of peroxisomal β-oxidation disorders},
journal = {Journal of Lipid Research},
year = {2024},
volume = {65},
number = {3},
pages = {100516},
doi = {10.1016/j.jlr.2024.100516}
}
EUVIMED